PureCycle Finalizes $395M Concurrent Stock and Convertible Note Offerings
PCT sits 69% above its 52-week low of $4.93 on elevated volume (3.5× avg).
Summary
PureCycle Technologies finalized a $395 million capital raise through a common stock offering at a discount and convertible senior notes, aiming to strengthen its balance sheet and fund operations.
Key Events · Financing and Capital Events · PCT
-
Finalized $395 Million Capital Raise
PureCycle Technologies priced concurrent offerings totaling $395 million in gross proceeds, consisting of $250 million in 4.75% convertible senior notes due 2032 and $145 million from the sale of 17,661,388 shares of common stock.
-
Common Stock Priced at Discount
The common stock was offered at $8.21 per share, a discount to the last reported sale price of $9.885 on June 10, 2026, and today's price of $8.31.
-
Significant Dilution
The common stock offering alone represents approximately 9.67% of the company's market capitalization, with additional potential dilution from the convertible notes.
-
Debt Repurchase and Working Capital
Net proceeds of approximately $379.1 million will primarily be used to repurchase $216 million (principal amount) of existing 7.25% Green Convertible Senior Notes due 2030 for $246.3 million, and for general corporate purposes.
Analysis · PCT · Industrial Applications And Services
PureCycle Technologies has finalized the terms for its significant capital raise, securing $395 million through a concurrent offering of common stock and convertible senior notes. This financing is critical for the company, which recently reported increased cash burn, and will be used to repurchase existing convertible debt and for general corporate purposes. The common stock was priced at a discount to recent trading levels, leading to substantial dilution for existing shareholders.
At the time of this filing, PCT was trading at $8.31 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $4.93 to $17.37. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.